Ann Hynes
Stock Analyst at Mizuho
(5.00)
# 2
Out of 4,906 analysts
255
Total ratings
64.48%
Success rate
231.74%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| THC Tenet Healthcare | Maintains: Outperform | $184 → $194 | $174.65 | +11.08% | 15 | Jul 11, 2025 | |
| MOH Molina Healthcare | Maintains: Outperform | $400 → $330 | $176.44 | +87.03% | 9 | Jul 11, 2025 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $8 → $7 | $4.66 | +50.21% | 4 | Jul 11, 2025 | |
| CNC Centene | Maintains: Neutral | $71 → $40 | $27.43 | +45.83% | 8 | Jul 11, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $515 → $350 | $282.14 | +24.05% | 18 | May 16, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $200 → $173 | $139.63 | +23.90% | 15 | May 15, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $210 → $190 | $158.96 | +19.53% | 12 | May 15, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $37 → $32 | $21.64 | +47.87% | 11 | May 14, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $178 → $189 | $166.45 | +13.55% | 15 | Apr 9, 2025 | |
| MEDP Medpace Holdings | Maintains: Outperform | $400 → $355 | $308.88 | +14.93% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $305 → $316 | $223.43 | +41.43% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $455 → $505 | $276.45 | +82.67% | 4 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $155 | $149.79 | +3.48% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $76 | $61.64 | +23.30% | 10 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $18 | $10.95 | +64.38% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $12.64 | +18.67% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $158.58 | -24.33% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $19.71 | +1.47% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $19.95 | +40.35% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $110.00 | -13.64% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $294.80 | +30.60% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $168.75 | +18.52% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.97 | +13,504.06% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $711.21 | -28.99% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $243.04 | -5.37% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $364.55 | -24.56% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $25 | $11.52 | +117.01% | 8 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $22.35 | +123.76% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.58 | +3,507.59% | 1 | Sep 21, 2017 |
Tenet Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $184 → $194
Current: $174.65
Upside: +11.08%
Molina Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $400 → $330
Current: $176.44
Upside: +87.03%
Fortrea Holdings
Jul 11, 2025
Maintains: Neutral
Price Target: $8 → $7
Current: $4.66
Upside: +50.21%
Centene
Jul 11, 2025
Maintains: Neutral
Price Target: $71 → $40
Current: $27.43
Upside: +45.83%
UnitedHealth Group
May 16, 2025
Maintains: Outperform
Price Target: $515 → $350
Current: $282.14
Upside: +24.05%
ICON Public Limited Company
May 15, 2025
Maintains: Outperform
Price Target: $200 → $173
Current: $139.63
Upside: +23.90%
IQVIA Holdings
May 15, 2025
Maintains: Outperform
Price Target: $210 → $190
Current: $158.96
Upside: +19.53%
Acadia Healthcare Company
May 14, 2025
Maintains: Neutral
Price Target: $37 → $32
Current: $21.64
Upside: +47.87%
Quest Diagnostics
Apr 9, 2025
Maintains: Outperform
Price Target: $178 → $189
Current: $166.45
Upside: +13.55%
Medpace Holdings
Apr 9, 2025
Maintains: Outperform
Price Target: $400 → $355
Current: $308.88
Upside: +14.93%
Apr 9, 2025
Maintains: Outperform
Price Target: $305 → $316
Current: $223.43
Upside: +41.43%
Apr 9, 2025
Maintains: Outperform
Price Target: $455 → $505
Current: $276.45
Upside: +82.67%
Apr 9, 2025
Maintains: Neutral
Price Target: $175 → $155
Current: $149.79
Upside: +3.48%
Apr 9, 2025
Maintains: Outperform
Price Target: $70 → $76
Current: $61.64
Upside: +23.30%
Apr 9, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $10.95
Upside: +64.38%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $12.64
Upside: +18.67%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $158.58
Upside: -24.33%
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $19.71
Upside: +1.47%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $19.95
Upside: +40.35%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $110.00
Upside: -13.64%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $294.80
Upside: +30.60%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $168.75
Upside: +18.52%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.97
Upside: +13,504.06%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $711.21
Upside: -28.99%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $243.04
Upside: -5.37%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $364.55
Upside: -24.56%
Oct 10, 2023
Maintains: Neutral
Price Target: $31 → $25
Current: $11.52
Upside: +117.01%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $22.35
Upside: +123.76%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.58
Upside: +3,507.59%